It has been postulated that the expression of the ribonucleoprotein te
lomerase is necessary to overcome cellular senescence and that maligna
nt tumors must express telomerase to maintain their immortality. In mo
st human adult tissues, telomerase activity is not detected. In contra
st, several murine tissues express various levels of telomerase. Mouse
skin however, does not show telomerase activity. Using the mouse skin
chemical carcinogenesis system, a well-characterized model for studyi
ng premalignant and malignant progression, we assayed telomerase activ
ity at various stages of premalignant papilloma progression by means o
f the recently developed telomeric repeat amplification protocol. We o
bserved that at 10 weeks of promotion, only one mouse skin papilloma o
f 11 analyzed showed high levels of telomerase activity. The number of
papillomas showing higher levels of telomerase activity increased at
20 weeks, and at 30 weeks of promotion, 100% of papillomas expressed s
ignificantly higher levels of telomerase. We learned from previous stu
dies that early papillomas are diploid, well-differentiated lesions, w
hereas late papillomas are aneuploid and very dysplastic. It appears t
hat the progressive increase in telomerase activity is associated with
the increased level of genomic instability and the phenotypic progres
sion of these premalignant tumors. It is also possible, however, that
the increase in telomerase activity could be in part a consequence of
an increase in the proportion of proliferating cells. Nevertheless, th
e mouse skin system mag be a very useful in vivo model for the study a
nd development of anti-telomerase therapeutic strategies.